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Background: There is disagreement among studies of health-related quality of life (HRQoL) changes in breast
cancer patients over time. Reportedly, assessment of HRQoL prior to diagnosis may be crucial to provide a clear
point of comparison for later measurements. The aims of this study were (1) to investigate changes in HRQoL,
sense of coherence (SOC), spirituality and religious coping in a group of women with breast cancer from the
pre-diagnosis phase to 6 months later in comparison with a control group, and (2) to explore the predictor role
of SOC, spirituality, and religious coping within the breast cancer group at the 6-month follow-up.
Methods: A sample of women with breast cancer (n = 162) and a matched control group (n = 210) responded to
the following instruments on both occasions: the European Organization for Research and Treatment of Cancer
QLQ-C30, the SOC Scale, the Spiritual Perspective Scale and the Brief Religious Coping Scale. A series of General
Linear Model (GLM) Repeated Measures was used to determine changes between the groups over time. Also,
Multiple Linear Regression analyses were applied to each of the HRQoL dimensions, as dependent variable at the
6 months follow-up.
Results: Physical and role function, fatigue, and financial difficulties were rated worse by the women with breast
cancer during the first 6 months in comparison to the controls, which was both a statistically (p < 0.001) and
clinically significant difference. Women had better scores for global quality of life (p < 0.001), and emotional
functioning (p < 0.01) during the same period of time. The degree of SOC (p < 0.01) and baseline ratings of several
dimensions of HRQoL (p < 0.05) were the most important predictors of HRQoL changes.
Conclusions: Collecting HRQoL data before a final diagnosis of breast cancer is important to identify women at risk
of deterioration in HRQoL during and after treatment. Special attention should be paid to physical and role
functioning impairment, fatigue, and financial difficulties experienced by these women. These results underscore
that the degree of SOC may be more important as a predictor for HRQoL changes in this sample than spirituality
and religious coping.
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Breast cancer is the most common cancer in women,
both in high-income and low/middle- income countries
[1]. It is a prevalent cancer in Iranian women, ranking first
among malignancies and fifth among causes of death [2].
It seems that in Iran, like in other middle-income coun-
tries, breast cancer appears in women at least one decade
younger than their counterparts in high-income countries
[3]. At the national level in Iran, mammography screening
for breast cancer is not routinely scheduled [4], so early
detection of breast cancer remains an essential challenge
[5]. Being diagnosed with breast cancer may be experi-
enced as a psychosocial transition connected with negative
as well as positive consequences [6]. Thus, living with
breast cancer often involves changes in life, especially re-
garding Health-related Quality of life (HRQoL) [7,8].
Commonly HRQoL is defined as multidimensional,
contextual, dynamic, and subjective concept which is re-
lated to a medical condition [9]. It is an important out-
come variable in cancer patients [10], because it affects
the prognosis, and it can be used for patient monitoring,
clinical decision-making, treatment, symptom manage-
ment and planning of supportive care interventions [11].
It is suggested that when measuring HRQoL in patients
with cancer a complex set of physical, mental and social
dimensions and disease-specific symptoms, should be
evaluated [12].
HRQoL changes in breast cancer patients over time
show discrepant results [13-15]. Some studies show that
follow-ups within 6 months after diagnosis yield signifi-
cant improvements in most HRQoL dimensions over
time [16,17], although some problems may still remain
(e.g., poor body image and an uncertain view of the
future, in addition to systemic therapy side effects) [18].
Other studies show reduced [15,19] or stable HRQoL
[13] within the first 6 months after treatment. Most pro-
spective HRQoL studies have focused on a baseline at the
time of the cancer diagnosis [13,20] or the post-diagnosis
period [21,22].
Understanding the ways patients cope with a cancer
diagnosis and treatment is important in determining their
HRQoL [9]. There are several ways to measure coping
with life strain. The concept of sense of coherence (SOC),
although being an area under discussion, has a broad
theoretical base and a growing body of empirical evi-
dence, supporting its utility as a determinant for suc-
cessful coping [23]. The concept of SOC is defined as an
individual’s global view of life, and as an inner resource
for coping with stressful life events, and thus does not
refer to a particular coping strategy [24]. The SOC is
built upon a dynamic interrelation between three compo-
nents: comprehensibility, manageability, and meaningful-
ness. Individuals with a higher SOC try to perceive their
life as more manageable, meaningful, and comprehensible,and these abilities are hypothesized to decrease the ten-
sions in life [24]. The theory behind the SOC suggests that
in adulthood (to about 30 years of age) it is a stable trait
and may only fluctuate when radical life events occur [24].
The concept is operationalized into a self-administered
instrument, the SOC scale which measures an individ-
ual’s SOC. Both the validity and reliability, including
cross-cultural adaptation of the scale (translated to 33
languages) have been supported in numerous studies
[25], including cancer populations [26-28]. Some studies
suggest that the SOC changes over time in adults [29,30].
Other studies, however, support clearly the stability of the
SOC [31,32] and a review concludes that variations over
time are small in adults [25]. Studies show that a high
SOC serves as a determinant for successful adaptation to
stressful situations, and is correlated to better health and
quality of life within different samples [33-35], also in
women with breast cancer [26].
Other personal inner resources that are also suggested
to be important when determining HRQoL are spirituality
[36,37] and religious coping [38,39]. Although the import-
ance of spirituality and religious coping may be different
across various cultures [40], there is growing evidence that
these concepts may be main resources when an individual
is confronted with a potentially life-threatening disease
[41-43]. Spirituality has been explained as a construct that
expands further than religiousness. Through spirituality
individuals attempt to perceive their world, themselves,
their requirements and their connection to self, others,
nature and God [44]. Reed [45] underlines that spirituality
is a form of self-transcendence, and defines it as an indi-
vidualized awareness of one’s inner self and a sense of
conjunction with a powerful dimension or purpose. She
developed the spiritual perspective scale (SPS) for measur-
ing one aspect of spirituality, spiritual perspective, in a
way that could be meaningful in different settings and
health conditions [46]. The SPS refers mainly to spiritual
behaviors and beliefs, and does not include subscales
which refer to well-being [47].
Religious coping, a close but not interchangeable con-
cept, was defined as efforts to perceive and manage life
stressors in a way linked to the notion of God or divinity
[38]. Religious coping consists of a positive dimension,
reflecting strategies to maintain a secure relationship
with God/a higher power, and a negative dimension,
reflecting a religious struggle [48]. Pargament [48] devel-
oped the religious coping (RCOPE) scale for measuring
of this concept from his theory. The RCOPE scale repre-
sents a different approach to religious assessment. This
scale is not measuring intrinsic and extrinsic religious
orientation, unlike earlier assessments of religiosity, even
though it may be correlated to these [38]. Generally,
positive religious coping was associated with improve-
ments in health, and negative religious coping predictive
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giously over time may be at risk for health-related prob-
lems [49]. Negative religious coping has been recognized
as a robust predictor of health-related outcomes [38].
Spirituality and religious coping correlate to physical
and mental health [38,50] and have been found to pre-
dict HRQOL among cancer survivors [51,52].
The differences between studies on how women with
breast cancer perceive HRQoL may depend on how the
term HRQoL is defined and measured [9,53]. Measure-
ment of HRQoL prior to diagnosis may be crucial to
provide a clear point of comparison for later measure-
ments, and could make a more reliable interpretation of
the results possible [54]. Furthermore, to cover all di-
mensions of HRQoL related to theory and the context of
culture, the use of several instruments is required [9]. In
numerous studies in Iran the importance of spiritual
and religious beliefs among patients with breast cancer
has raised interest [55,56], but no previous studies have
applied the concept of SOC in this population to date.
Therefore, the main aims of this study were to investi-
gate changes in HRQoL, SOC, spirituality and religious
coping in a group of women with breast cancer from the
pre-diagnosis phase to 6 months later, compared with a
matched control group and to explore the predictor role
of SOC, spirituality, and religious coping within the
breast cancer group at the 6-month follow-up. HRQoL
was measured by the European Organization for Re-
search and Treatment of Cancer (EORTC) QLQ-C30, a
specific questionnaire for cancer patients [9], and the
SOC, spirituality and religious coping were measured by
standardized scales. Additionally, we discuss the predic-
tors of HRQoL dimensions at the 6-month follow-up
with focus on baseline HRQoL data and the SOC, spir-
ituality and religious coping.
Methods
Design
This study was longitudinal with a prospective and com-
parative design at two time points: baseline (pre-diagnosis
phase of breast cancer) (T1) and 6 months post pre-
diagnosis (T2).
Samples
Inclusion criteria for both groups consisted of having
sufficient knowledge of the Persian language to answer
the questionnaires and no previous cancer history.
Breast cancer group
During several months, five days a week after checking
the admission books in the nursing stations, a prospect-
ive sample of 254 women with an operable lump in the
breast or other symptoms indicative of breast cancer
were approached by the first author before surgery (thepre-diagnosis phase) at the surgical wards of two educa-
tional hospitals in Tehran. One of the hospitals is a
center for cancer patients, with 1300 beds and 4300 em-
ployees, the other is a center for women’s diseases, with
111 beds and 344 employees. Both hospitals together
treat around 750 breast cancer patients annually, includ-
ing newly diagnosed and follow-up patients. In total 254
women met the inclusion criteria, but 92 participants
(36%) dropped out by the end of the 6-month follow-up,
leaving a final sample of 162 patients (64%) (Figure 1).
At baseline, both the patients and the authors were blind
to the final diagnosis. The breast cancer diagnosis was
confirmed with a quick pathology report during surgery.
This report was thereafter controlled in detail, and the
final result was given to the patients two to three weeks
later. Women with a confirmed diagnosis of breast cancer
were included in the study’s follow-up, and those with be-
nign results were excluded (n = 39). There was no exclu-
sion from the study with regard to type of breast cancer,
disease stage, and having or not having a pre-surgery
biopsy report. After surgery, the patients underwent a
single or combined treatment modality (chemotherapy,
radiotherapy and hormonal therapy), based on National
Comprehensive Cancer Network Guidelines [57].
Control group
During several months, using consecutive odd queue
numbers, three days of a week, in total 880 women were
randomly selected by a trained colleague from the Mam-
mography Centers at the same hospitals before undergo-
ing mammography/breast ultrasonography. These women
visited the centers by referral from a physician, based on
their own or the physician’s initiative. Of the 880 eligible
women, 167 participants (19%) did not return the ques-
tionnaires, 21 (2%) declined further participation, 43
(5%) had changed their address and 10 (1%) were diag-
nosed with breast cancer, leaving 639 women (73%) at
the 6-month follow-up. A sub-sample of 210 partici-
pants was drawn by frequency matching, (see Statistical
analyses) (Figure 1).
Measurements
The European Organization for Research and Treatment
of Cancer QLQ-C30 (EORTC QLQ-C30) version 3 (30
items) is a core cancer-specific questionnaire, and includes
a global health status/quality of life scale, five functional
scales (physical, role, emotional, cognitive, and social func-
tioning), three symptom scales (fatigue, pain, and nausea/
vomiting) and six single items (appetite loss, insomnia,
dyspnea, constipation, diarrhea, and financial difficulties).
All of the scales and single-item measures are transformed
to scores ranging from 0 to 100. A high score represents a
high global quality of life and functioning or a high level
of symptoms. The validity and reliability of the instrument
Breast cancer group  Control group
Assessed for eligibility  
(n= 254) 
Assessed for eligibility  
(n= 880) 
Participants at baseline 
(T1) (n= 190) 
Participants at baseline 
(T1) (n= 713) 
Included benign tumors 
(n=160) 
Participants at 6- month 
follow-up (T2) (n= 162) 
Participants at 6-month 
follow-up (T2) (n= 639) 




Benign tumors (n=39) 
Declined further participation 
(n=23) 
Change of address (n=4) 
Deceased (n=1) 




Change of address (n=43) 
Diagnosis with breast cancer 
(n=10) 
Matched participants at 
T1 and T2 (n=210)  
Figure 1 Flow chart of sampling for the breast cancer and control groups.
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[58,59]. The ability of the EORTC QLQ-C30 to detect
HRQoL differences in the normal population has also
been confirmed [60]. In our study, all Cronbach’s alpha
coefficients for the EORTC QLQ-C30 scales at T1 were
on the suggested level (>0.60) [9] in both groups, except
for three scales in the breast cancer group: role func-
tioning (0.46), cognitive functioning (0.44) and nausea/
vomiting (0.44). The low coefficients for these scales
could be due to the low number of items on these scales
[61], and this is consistent with some previous findings as
well [13,59]. However, all scales of the EORTC QLQ-C30
in the breast cancer group met the criterion (Cronbach’s
alpha coefficient > 0.60) at T2.
The Sense of Coherence (SOC) scale includes 13 items
for which the respondents indicate agreement or dis-
agreement on a seven-point scale. The total score can
range from 13 to 91, with higher scores representing a
higher SOC [24]. The SOC scale has demonstrated satis-
factory psychometric properties with cross-cultural ap-
plicability [25], including validity of the Iranian version
[62]. In the present study Cronbach’s alpha coefficients
were > 0.77 in both groups on both occasions.
The Spiritual Perspective Scale (SPS) is a 10-item scale
that measures the extent to which individuals hold
certain spiritual beliefs and engage in spiritually related
behaviors [46]. Each item ranges from 1 to 6, and the
items are summed to one scale summary (10–60 points),
where a higher score represents a stronger spiritualperspective. The scale is organized to reflect spiritual be-
haviors (4 items) and spiritual beliefs (6 items) [63]. One
example of the items of spiritual behaviors is: “How
often do you engage in private prayer or meditation?.”
Responses are: 1 (not at all), 2 (less than once a year), 3
(about once a year), 4 (about once a month), 5 (about
once a week), and 6 (about once a day). One example of
the spiritual belief items is: “My spiritual views have had
an influence upon my life.” Responses are: 1 (strongly
disagree), 2 (disagree), 3 (disagree more than agree), 4
(agree more than disagree), 5 (agree), and 6 (strongly
agree). None of the items refers to a specific religion
[63]. The psychometric properties of this instrument
have been demonstrated within different samples [64],
including the Iranian version [62]. In the present study
Cronbach’s alpha coefficients were > 0.78 in both groups
on both occasions.
The Brief Religious Coping (Brief RCOPE) scale is used
to assess religious coping. It comprises 14 items, each on a
four-point rating scale from “not at all” to “a great deal”,
that distinguish between positive and negative religious
styles. Seven items reflect positive religious coping, includ-
ing strategies such as looking for spiritual support and
benevolent religious reappraisals, e.g. “Looked for a stron-
ger connection with God”. Seven items reflect negative re-
ligious coping and contains items related to spiritual
struggle, such as “Wondered whether God had abandoned
me” [48]. The scoring range for each scale is from 7 to 28:
the higher the score, the stronger the positive/negative
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of the Brief RCOPE has been reported [48], including an
Iranian version of the scale [62]. Cronbach’s alpha coeffi-
cients of both scales were 0.80 and above in both samples
on both occasions.
Demographic data for both groups were collected at the
first visit by questions about age, marital status, working
status, and educational level. Clinical data for the breast
cancer group was obtained from medical records (meno-
pause, comorbidity, cancerous body side, biopsy before
surgery, type of surgery, stage, and treatment type), and
for the controls by a self-reported questionnaire (meno-
pause and comorbidity).
Data collection
The study was approved by the National Ethical Board
of Research at the Ministry of Health and Medical Edu-
cation of Iran (P/391-31). The participants in both
groups were given verbal and written information about
the study, and written informed consent was obtained
from all of them. The information explained the study
objectives of comparing women diagnosed with breast
cancer, with those without breast cancer. All women
were in a more or less vulnerable situation with a poten-
tial breast cancer diagnosis. The researcher emphasized
voluntariness and the right to withdraw from further
participation at any stage of the study.
Baseline data for the breast cancer group were collected
by the EORTC QLQ-C30, the SOC scale, the SPS, and the
Brief RCOPE scale on days 1–14 before surgery. In the
controls, the same assessments were completed before
undergoing mammography/breast ultrasonography exam-
ination at the Mammography Centers. At baseline, the
questionnaires were collected at the hospital. Six months
later, the same questionnaires accompanied by an infor-
mation letter and a pre-stamped envelope were sent via
post to the participants in both groups.
Statistical analyses
A priori power analysis by G* Power 3 version 3.1.5.1,
with an estimated effect size of 0.3 according to earlier
studies [22,65], showed that a minimum of 235 subjects
should be included in the study for each group to detect
changes by a power of 90% at 0.05 significant level. Esti-
mating about 10% drop-out rate, 254 women suspected
of having breast cancer were approached. During the
same time, women in the control group were randomly
recruited, and the final sample included 880 women, in
order to facilitate post stratification and matching with
the breast cancer group. A posteriori power analysis
showed that the remaining samples by the end of the
study detected changes by a power of 80% at 0.05 signifi-
cant level in the breast cancer (n = 162) and control
groups (n = 210).According to the initial analysis of the data, differences
between the two groups appeared, and therefore, after
post stratification, frequency matching was applied [66].
The sample size allowed for six matching variables: age,
education, marital and working status, menopausal sta-
tus, and existence of comorbidities. Outcome variables
met the normality assumptions by P-P plots. For all ana-
lyses, the significance level was set at p < 0.05. Mean dif-
ferences within the groups were estimated by the
dependent Student’s t-test from T1 to T2, and between
the groups by the independent Student’s t-test.
All scales were linearly transformed to 0–100 scores,
and the interaction effect between time (T1 vs. T2) and
group (breast cancer group vs. the controls) on the out-
come variables was estimated. Therefore, a series of gen-
eral linear model (GLM) repeated measures were run
with the number of comorbidities as a covariate (still
significantly different between the groups after matching,
see results section), to determine adjusted mean score
differences between the groups over time. The degree of
clinical changes and their directions was calculated from
the results of the GLM analyses by adjusted mean differ-
ences between the groups. Clinical changes were inter-
preted in terms of small (5–10), moderate (11–19), or
large (≥20) [67].
Ahead of multiple linear regression (MLR) analyses, a
correlation matrix was generated between demographic
and clinical variables and HRQOL variables in the breast
cancer group at T2 to explore which of them should be
included as independent variables. Those that resulted
with statistical significance were age, education, surgery
type, cancer stage, and treatment modalities. The SOC
scale, SPS and the Brief RCOPE scale scores and base-
line scores of HRQoL dimensions were also independent
variables, based on their earlier confirmed predictor
value in HRQOL studies. Subsequently, independent
variables were entered into the MLR analyses in four
blocks: demographic variables (dichotomized, except for
age), clinical variables (dichotomized), the SOC, the SPS,
and the Brief RCOPE scale scores at T2, and baseline
score of HRQoL dimensions. MLR analyses were run
with each of the HRQoL dimensions at T2 as dependent
variables. Multicollinearity among the SOC, SPS and
Brief RCOPE scores, in addition to the rest of MLR as-
sumptions (normal distribution of the residuals and ho-
moscedasticity) were tested and fulfilled [68]. Statistical
analyses were conducted using the SPSS version 17.0
(SPSS Inc., Chicago, IL, USA, 2008).
Results
Descriptive data
Demographic and clinical characteristics of the two
groups are summarized in Tables 1 and 2. The mean age
of the breast cancer and control group were, respectively
Table 1 Demographic and clinical data in the breast cancer (n = 162) and control groups (n = 210)
Demographic & clinical variables Breast cancer group n (%) Control group n (%) df p value
Age in years, Mean (SD) 46.1 (9.8) 46.6 (8.4) 370 .071a
Marital status 2 .572b
Single 11 (6.8) 24 (11.4)
Married 129 (79.6) 170 (81.0)
Divorced/Widowed 22 (13.6) 16 (7.6)
Education 1 .557b
Primary school 23 (14.2) 35 (16.7)
Secondary school 27 (16.7) 23 (11.0)
High school 4 (2.5) 6 (2.9)
Diploma 57 (35.2) 75 (35.7)
University 51 (31.5) 71 (33.8)
Working status 2 .356b
Housewife 97 (59.9) 117 (55.7)
Employed 51 (31.5) 65 (31.0)
Retired 14 (8.6) 28 (13.3)
Menopause at beginning of the study 1 .349b
Yes 60 (37.0) 68 (32.4)
No 102 (63.0) 142 (67.6)
Comorbidity c 1 .935b
Yes 78 (48.1) 102 (48.6)
No 84 (51.9) 108 (51.4)
Number of comorbidities 1 .001b
One 42 (26.0) 30 (14.3)
More than one 36 (22.0) 72 (34.3)
aDifferences between groups’ proportions were tested by the Independent Student’s t-test.
bDifferences between groups’ proportions were tested by the Chi-Square.
cComorbidity: long-standing diseases such as diabetes, hypertension, and musculoskeletal problems.
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patients and the controls had an education at less than
university level (68.5%, 66.2%), were married (79.6%,
81%), housewives (59.9%, 55.7%), and in a premeno-
pausal stage (63%, 67.6%) (Table 1).
Furthermore, most patients underwent a mastectomy
(55.6%) and most had a combined treatment modality
(84%) after surgery (Table 2). At the 6-month follow-up,
33% of the patients were in the treatment end point
phase and the rest of them have been free of treatments
for at least one week (Table 2).
The groups differed in several scale scores at T1
(Table 3). The patients reported significantly lower glo-
bal quality of life, emotional and social functioning, and
more appetite loss and financial problems than the con-
trols, combined with higher physical, role, and cognitive
functioning, and lower constipation. The breast cancer
group also had higher scores than the controls on the
SOC, spirituality, and positive religious coping at T1.Changes over time
Changes within the breast cancer group indicated that
these women had poorer scores at T2 on the functional
(physical, role, cognitive, and social functioning) and
symptom scales (fatigue, nausea/vomiting, pain, consti-
pation, and financial difficulties), in addition to the
lower scores for the SOC, spirituality, and positive reli-
gious coping, compared with T1 (Table 3). However,
they had better scores for global quality of life and emo-
tional functioning at T2 than at T1. Within the control
group, all scale scores remained stable between T1 and
T2 (Table 3).
The differences between the two groups were signifi-
cant for most outcome variables (lower functional and
more symptom scales scores) in the breast cancer group
compared with the controls at T2. But, the changes of
SOC and religious coping scales scores were not signifi-
cant and only the spirituality scale scores showed a sig-
nificant decrease in the breast cancer group compared
with the controls at T2 (Table 3).
Table 2 Specific clinical characteristics of the breast
cancer patients (n = 162)
Variable n Percent (%)
Breast cancer
One side 159 98.1






















Combined & single treatment modality
CT + RT + HT 62 38.3
CT + RT 35 21.6
CT + HT 16 9.9




Treatment at the 6-month follow-upa
Ongoing treatment 53 32.7
Treatment ended 1–2 weeks before follow-up 75 46.3
Treatment ended more than 1 month before
follow-up
34 21.0
CT: Chemotherapy; HT: Hormonal therapy; RT: Radiotherapy.
aIt includes just CT and RT.
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(GLM repeated measures), a significant interaction effect
was found between time and group from T1 to T2 in
the breast cancer group, compared with the controls, for
some of the EORTC QLQ-C30 scale scores, and for theSOC, spirituality, and positive religious coping scales
scores. In comparison with the controls, the breast can-
cer group scored lower on the physical, role, cognitive
and social functioning scales scores, and reported more
symptoms scale scores (fatigue, nausea/vomiting, pain,
constipation, and financial difficulties) over time. Fur-
thermore, the breast cancer group rated decreased
scores in SOC, spirituality, and positive religious coping,
but increased scores on global quality of life and emo-
tional functioning over time from T1 to T2. Impaired
areas of physical and role functioning, more fatigue and
financial difficulties were clinically significant in the
breast cancer group, compared with the controls over
time (Table 4).
Predictors of HRQoL in the breast cancer group at T2
The results of the MLRs (Table 5) showed that the
strongest predictors of the EORTC QLQ-C30 scales
were the degree of SOC (p < 0.01) and baseline ratings of
several dimensions of HRQoL (p < 0.05), 6 months after
the pre-diagnosis phase of breast cancer. The spirituality
and religious coping scores did not predict the scales of
the EORTC QLQ-C30.
Discussion
With the objective to determine why pattern of changes
in HRQoL differ between studies during the illness tra-
jectory for patients with breast cancer, we hypothesized
that obtaining pre-diagnosis ratings could be one way of
exploration. In that way all women are in a similar situ-
ation at baseline. In an ideal situation the recruitment
should have been from a national mammography screen-
ing program, but this does not exist in Iran. Hence, the
present study compared women in Iran, who were re-
ferred to the surgical wards for symptoms suggestive of
breast cancer and diagnosed as having breast cancer
later on, with a matched group of women who were vis-
iting the Mammography Center, and were not diagnosed
subsequently with breast cancer.
The baseline measurements differed between the groups.
The women in the breast cancer group rated their global
quality of life and emotional functioning worse, but they
were less physically affected. These results could be ex-
plained by the women referred for surgery and final diag-
nosis being in a more threatening situation [69] than the
controls, who visited Mammography Center by referral
from a physician, either for screening or other reasons.
On the other hand, fear of a cancer diagnosis and adverse
psychological reactions have been reported in women who
were referred for screening mammography programs as
well [70,71]. A study found that women with early-stage
breast cancer, in comparison to women among the general
population reported poorer emotional, cognitive, and so-
cial functioning as well as more insomnia, appetite loss,
Table 3 The results of the dependent and independent Student’s t-test in the breast cancer (n = 162) and control
groups (n = 210) at baseline (T1) and at the 6-month follow-up (T 2)















T1 T2 (p value) T1 T2 (p value) (p value) (p value)
EORTCQLQ-C30:
Global quality of life 0-100 58.1(20.1) 68.7 (18.5) .000 70.1 (21.6) 72.4 (18.0) .098 .000 .053
Functional scales:
Physical 0-100 93.8 (9.6) 77.4 (16.3) .000 85.5 (12.6) 85.2 (12.7) .713 .000 .000
Role 0-100 94.6 (12.3) 81.9 (19.3) .000 90.0 (16.4) 88.2 (16.8) .160 .002 .001
Emotional 0-100 55.2 (27.4) 65.3 (23.8) .000 72.5 (22.8) 74.0 (21.6) .335 .000 .000
Cognitive 0-100 87.9 (15.1) 83.3 (18.2) .009 82.5 (20.6) 84.0 (19.2) .261 .004 .716
Social 0-100 82.2 (21.3) 74.8 (24.6) .001 93.7 (14.5) 93.3 (15.0) .745 .000 .000
Symptom scales:
Fatigue 0-100 18.3 (18.4) 31.6 (23.3) .000 21.0 (16.4) 22.5 (19.3) .234 .130 .000
Nausea/vomiting 0-100 4.2 (9.3) 7.4 (16.2) .024 3.5 (9.1) 3.3 (9.7) .840 .452 .005
Pain 0-100 15.1 (17.4) 25.0 (21.9) .000 15.9 (19.9) 17.2 (19.9) .342 .699 .000
Dyspnea 0-100 8.4 (17.1) 11.3 (17.9) .090 8.1 (16.7) 9.4 (18.8) .326 .848 .311
Insomnia 0-100 22.0 (28.3) 26.5 (29.7) .076 18.1 (24.6) 18.6 (24.4) .788 .162 .006
Appetite loss 0-100 13.8 (23.1) 13.7 (24.0) .990 6.8 (15.0) 7.6 (16.1) .523 .001 .005
Constipation 0-100 8.2 (19.0) 15.2 (25.5) .001 12.8 (21.8) 12.4 (21.3) .761 .030 .253
Diarrhea 0-100 3.3 (11.3) 3.5 (10.9) .862 3.3 (10.0) 4.8 (14.1) .217 .970 .347
Financial difficulties 0-100 17.7 (29.0) 37.9 (34.3) .000 10.3 (22.7) 8.7 (19.4) .309 .008 .000
Sense of Coherence 13-91 67.2 (11.3) 63.1 (13.4) .000 61.9 (14.0) 62.9 (13.4) .171 .000 .870
Spiritual Perspective
Scale
10-60 54.5 (4.9) 51.5 (6.5) .000 49.0 (7.5) 49.2 (6.9) .424 .000 .001
Religious Coping (+) 7-28 24.1 (4.2) 22.8 (4.3) .000 22.8 (4.3) 22.9 (4.2) .684 .004 .806
Religious Coping (−) 7-28 11.5 (4.7) 12.0 (4.9) .135 12.3 (4.7) 12.0 (4.2) .322 .072 .927
1BC: breast cancer; 2C: Control, 3Paired t-test; 4Independent Student’s t-test.
Bold values show statistical significant differences within and between the groups.
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culties [13]. In our study the degree of SOC, spirituality,
and positive religious coping were rated higher in the
breast cancer group than in the controls at baseline. This
might depend on the threat of the disease influencing the
women early, a noticeable finding in the care process.
Women with breast cancer have earlier shown high spir-
ituality and religious coping [72,73]. Hence, with regard to
Iran as a predominantly religious-spiritual society [56],
these differences are not surprising. There is a lack of nor-
mative data for SOC, spirituality, and religious coping
scores in the Iranian population. However, in comparison
with a healthy sample collected in the same region [62],
the women with breast cancer had higher SOC, spiritual-
ity, and positive religious coping scores. In contrast, the
controls were closer to the norm mean values [62].
Patients within the breast cancer group reported im-
paired functions and increased symptoms 6 months after
the baseline measure, in contrast to improved perceptionof global quality of life and emotional functioning. A simi-
lar pattern has been reported in a prospective study with-
out a control group, 3 months after initial treatment in a
sample of Iranian women with breast cancer [65]. In par-
allel to our study, a Scandinavian study reported decreased
physical, role, and social functions, and increased emo-
tional functioning and fatigue among women with breast
cancer. However, those women had a decreased global
quality of life up to 25 weeks after chemotherapy, which
was contrary to our findings [74]. Probably, most patients
recover from their first emotional reactions during the
first 6 months [14], although the impact of different adju-
vant treatments and their side effects are likely to increase
[18]. In our study, at the 6-month follow-up only a small
proportion of the patients were in the treatment endpoint
phase which was controlled for in the regression analyses.
However, other prospective studies within the first
6 months showed different results. A prospective study
with a 3-month follow-up after diagnosis showed no
Table 4 The results of the GLM repeated measures and clinical changes over time according to the adjusted mean
differences, for EORTC QLQ-C30, SOC, SPS, and RCOPE (+) and RCOPE (−) scale scores in the breast cancer group
(n = 162) compared to the controls (n = 210) from baseline (T1) to the 6-month follow-up (T2)
Variables GLM results interaction effecta Statistical changes over time (p value) Adjusted mean differences between
groups over timeb(Clinical changes)
Group * Time T1 → T2 T1 → T2
EORTCQLQ-C30:
Global quality of life 12.5 .000 +8.2
Functional scales:
Physical 118.5 .000 - 16.2
Role 30.1 .000 - 11.0
Emotional 9.8 .002 +8.5
Cognitive 7.9 .005 - 6.0
Social 8.4 .004 - 7.0
Symptom scales:
Fatigue 22.7 .000 +12.0
Nausea/vomiting 4.7 .030 +3.4
Pain 13.3 .000 +8.6
Dyspnea 0.6 .419 +1.7
Insomnia 1.7 .184 +4.0
Appetite loss 0.1 .707 - 1.0
Constipation 8.6 .004 +7.5
Diarrhea 0.4 .545 - 1.1
Financial difficulties 51.7 .000 +21.7
Sense of Coherence 17.3 .000 - 6.5
Spiritual Perspective Scale 31.0 .000 - 6.6
Religious Coping (+) 9.8 .002 - 6.5
Religious Coping (−) 3.5 .060 +4.3
In the last column plus and minus signs represent a higher or lower scoring on the respective variable.
Higher scoring (+) for symptom scales and RCOPE (−) scale shows impairment over time.
aGLM repeated measures tests adjusted for the number of the comorbidities.
bDifferences in adjusted mean score in the breast cancer group (T2 - T1) minus differences in adjusted mean score in the controls (T2 - T1) show clinical changes
(Criterion: small 5–10, moderate 11–19, and large ≥ 20).
Bold values show significant statistical and clinical changes in the breast cancer group compared to the controls over time.
All scales were linearly transformed to 0–100.
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fatigue, nausea/vomiting, and financial difficulties of pa-
tients with breast cancer in comparison to the general
population, although role, emotional, cognitive, and social
functioning deteriorated and pain decreased [13]. The
findings of a 2-year follow-up study indicated that the
greatest improvements appeared in almost all HRQoL di-
mensions during the first 6 months after surgery [22]. The
diversity among study results may depend on several fac-
tors such as various treatment regimens and different side
effects, absence of a control group, applying different in-
struments for assessing HRQoL, and the time of baseline
and follow-ups in relation to diagnosis. Our study and the
only other study using EORTC with a pre-diagnosis base-
line (without a control group and also from Iran) showed
similar results at baseline [65].The most important impairment areas for women with
breast cancer, compared with the controls over time
were physical and role functioning, fatigue and financial
difficulties. These areas have previously been distin-
guished as being areas of concern in some studies, both
during and after treatment [15,65]. Therefore, it is im-
portant to plan for the impact of the disease trajectory
and the effects of adjuvant treatments on the patients’
HRQoL and its dimensions [7]. Physical and role impair-
ment as well as fatigue may continue for a long period
postoperatively and threaten the patients’ independence
[75]. Financial difficulties were highly prominent in our
study, a finding that has been reported both in high-
income and in low/middle-income countries [15,76]. Fi-
nancial burden may result from several causes, including
work absence, costs of treatment and traveling to and
Table 5 The results of the multiple linear regression analyses for HRQoL dimensions, summary of the significant
predictors for the scales of the EORTC QLQ-C30 in the breast cancer group (n = 162) at the 6-month follow-up
Dependent variables βb p value Dependent variables βb p value
Global quality of life Pain
Education 0.21 .003 Disease stage 0.17 .032
SOC 0.50 .000 SOC -0.26 .003
R2 = 0.33 PA-baseline 0.20 .012
Physical Functioning R2 = 0.16
Disease stage -0.19 .012 Dyspnea
SOC 0.31 .000 DY-baseline 0.26 .001
PF-baseline 0.27 .000 R2 = 0.16
R2 = 0.26 Insomnia
Role Functioning SOC -0.39 .000
Disease stage -0.17 .036 SL-baseline 0.36 .000
SOC 0.33 .000 R2 = 0.30
R2 = 0.19 Appetite Loss
Emotional Functioning Education -0.27 .001
Surgery type -0.22 .001 Disease stage 0.17 .034
SOC 0.49 .000 SOC -0.27 .001
R2 = 0.40 R2 = 0.17
Cognitive Functioning Constipation
Age 0.16 .041 CO-baseline 0.25 .001
SOC 0.26 .002 R2 = 0.13
RCOPE (−) -0.17 .034 Diarrhea
R2 = 0.21 Disease stage 0.27 .001
Social Functioning R2 = 0.12
SOC 0.33 .000 Financial Difficulties
R2 = 0.25 SOC -0.26 .002
Fatigue FI-baseline 0.28 .000




CO: constipation; DY: dyspnea; FA: fatigue; FI: financial difficulties; PA: pain; PF: physical functioning; RCOPE (−): negative religious coping; SL: insomnia; SOC: sense
of coherence.
Coding of the independent variables: age (continuous variable), education (lower education: high school and lower levels; higher education: college and
university), disease stage (mild: 0 to II or severe: III and higher), surgery type (mastectomy or conservation surgery), and treatment modalities at the 6-month
follow-up (ongoing treatment or treatment ended).
β^ : Standardized regression coefficient.
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coverage of at least one kind of health insurance for
more than about 90% of Iranian inhabitants, and govern-
mental support of health costs, out-of-pocket expend-
iture on health remains as high as 55% for the Iranian
population [78].
After adjustment for the number of the comorbidities,
the degree of SOC, spirituality and positive religious
coping showed a small decrease in the breast cancergroup in comparison to the controls over time, but these
changes were not clinically important. These small
changes make it uncertain whether these variables are
stable or change over time. There are probably minor or
slow changes in the level of SOC after exposure to
stressful situations, as Antonovsky explained [24]. Fur-
thermore, these data present initial evidence that spiritu-
ality and religious coping may be sensitive to changes
during the disease diagnosis and treatment phases, but
Rohani et al. Health and Quality of Life Outcomes  (2015) 13:40 Page 11 of 14this needs more consideration through longitudinal
studies with different samples [38,79].
After controlling for demographic data and the treat-
ment modalities at the 6 months follow-up, the degree
of SOC and baseline ratings of several dimensions of
HRQoL were the most important variables, predicting
changes in the level of both some physical and mental
dimensions of HRQoL 6 months after the pre-diagnosis
period of breast cancer. It has been reported that the
SOC seems to be stronger correlated to the mental di-
mension than the physical [33]. In our study the predict-
ive role of the SOC for both types of dimensions of
HRQoL is almost comparable. The importance of a pre-
diagnosis rating of HRQoL dimensions in women with
breast cancer becomes more obvious here. It has been rec-
ognized that baseline ratings of HRQoL can be predictive
of health outcomes, such as survival rate, and response to
the treatment in cancer patients over time [80,81]. In our
study higher baseline ratings of physical functioning im-
pairment and several symptoms were the most important
predictors for the same HRQoL dimensions 6 months
after the pre-diagnosis phase of breast cancer.
The value of SOC as an important predictor of HRQoL
changes has been supported by the results of several stud-
ies [26,27,82]. Higher SOC as an inner resource may imply
a stress buffering power, which contributes to better adap-
tive abilities in specific situations [24]. The power of spir-
ituality and religious attitudes on the prediction of
HRQoL has been shown in several studies in a Muslim
context [55,83,84]. But in our study, the influence of the
degree of SOC was more pronounced than spirituality and
religious coping. This is in line with the theory of SOC,
emphasizing the importance of an individual’s overall view
of life on how to manage strain, rather than special coping
strategies [24]. Probably cancer opens many demands in a
patient’s life [7]. The role of the SOC can be regarded as
the ability to find and utilize resources. Key components
in the concept of SOC (comprehensibility, manageability
and meaningfulness) are the resources that are available to
supply energy and assist individuals to cope with the de-
mands of stressful life events. Thus, the SOC as an inner
resource is more clearly concentrated on factors pro-
moting health rather than factors that refer to particular
diseases [24]. Similar results regarding the SOC were
found in an earlier study by the authors, examining
SOC, spirituality and religious coping simultaneously as
predictors of well-being within a healthy sample of the
Iranian population [62].
Despite the potential effect of spirituality on HRQOL
in different studies [85,86], we didn’t find any significant
correlation in this study. A possible interpretation for
why the spirituality was not a predictor in our study
is that often the questionnaires measuring spirituality
have a distinction between an existential (a feeling ofmeaning, peace, and connection to the self and others)
and a religious dimensions (the belief and experience of
connection with a higher power). The existential dimen-
sion appears to be more associated with HRQoL [86]
and well-being than the religious dimension [47]. How-
ever, even if this shows that dimensions of spirituality
are individual, it does not mean spirituality has consider-
able overlap with core HRQoL dimensions, because the
correlations are not strong [87]. In our study, we chose
the SPS in which the items are categorized to reflect
spiritual behaviors and beliefs, but the SPS yields a single
score and Reed [46,64] who developed the SPS did not
discuss the subscales [63]. Therefore, our results under-
score that the degree of SOC as an overall view of life
and coping capacity, may be more important than spir-
ituality and religion, as a general predictor for HRQoL
changes. These findings suggest that testing the longitu-
dinal role of the SOC as a mediator or moderator in the
prediction of HRQoL in future research could contribute
to the knowledge base for the SOC in the psychological
adaptation of patients with breast cancer.
Baseline measurements at the pre-diagnosis phase to-
gether with a matched control group selection, is one of
the strengths of this study, but there are several limita-
tions. The groups did not differ after frequency match-
ing regarding age, education, marital and working status,
menopausal status, and existence of comorbidities. How-
ever, there were differences in the baseline HRQoL vari-
ables between the groups, which could be related to fear
of the diagnosis, surgery, and cancer treatment in the
breast cancer group and/ or a higher number of comor-
bidities reported by the controls. The difference in the
number of comorbidities may be due to the fact that
data were obtained from medical records in the breast
cancer group, but by a self-report questionnaire in the
control group. The reason being limited access to med-
ical records of the control group, as they were not pa-
tients at the hospitals after mammography. It should be
noted that subjective reports of comorbidities could
bring greater variation of the results, in comparison
with a validated record-based system [88]. This may also
indicate that the women already in hospital care, be-
cause of symptoms suggestive of breast cancer, may not
be fully comparable to the women who sought or were
referred to mammography, as also reflected in the de-
gree of SOC. Another potential bias was that data gath-
ering was done in the hospitals at T1. But at T2, the
questionnaires were posted by express mail, because
some patients were living in other cities, and would not
visit the hospitals in Tehran after initial treatment, as
follow-up treatments were done in local clinics. The
drop-out rate may have increased dramatically, if the
patients had to visit the hospital once again just to fill
out the questionnaires.
Rohani et al. Health and Quality of Life Outcomes  (2015) 13:40 Page 12 of 14Conclusions
During the first 6 months after pre-diagnosis, physical
and role functioning, fatigue, and financial difficulties
were prominent areas of impairment in HRQoL dimen-
sions in a sample of breast cancer patients compared
with a matched control group of women. In contrast,
during the same time span, the women with breast cancer
improved in overall quality of life and emotional function-
ing. The degree of sense of coherence and baseline ratings
of several dimensions of HRQoL are important predic-
tors for patient HRQoL changes at the 6-month follow
up rather than spirituality and religious coping. The
study corroborates Antonovsky’s suggestion regarding
cross-cultural applicability of the sense of coherence
concept in prediction of HRQoL changes. Our study re-
sults support the importance of collecting data concerning
HRQoL and sense of coherence early at the pre-diagnosis
period of breast cancer. Gathering sense of coherence data
together with HRQoL data can assist in early detection of
women who may be at greater risk for HRQoL impair-
ments and have lower ability to adapt to the disease and
treatment psychologically.
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